In partnership with
How advanced automation and miniaturization de-risk and accelerate biomanufacturing, from strain engineering and high-throughput screening right through to industrial scale-up.
Olivier Galy, PhD
CTO, Toulouse White Biotechnology
Maria Savino, PhD, MBA
Beckman Coulter Life Sciences
Complete the form to secure your access. A confirmation will be sent to your inbox.
Complimentary AccessThank you for signing up. Check your inbox for confirmation and joining details for the webinar.
Biofoundries are designed to accelerate biological research and biotechnology development by applying engineering principles, standardization, modularity, and automation, into biological workflows. This session explores strategic approaches that leverage advanced automation and miniaturization to de-risk and accelerate the development of new solutions across biomanufacturing.
Drawing on the PPTI podcast conversation with experts from Toulouse White Biotechnology and Beckman Coulter Life Sciences, the discussion covers how data integration, miniaturization, and standardized workflows come together to reduce both risk and cost, and how teams can adopt automation practically, without disrupting existing infrastructure.
Discover how automation and miniaturization optimize the entire biomanufacturing workflow, from strain engineering and high-throughput screening to culture optimization, de-risking scale-up.
Understand how automated, miniaturized platforms enable accelerated workflow development with a smaller footprint and increased throughput versus traditional approaches.
Explore the latest generation of user-friendly equipment that simplifies access to advanced automation, making next-generation biomanufacturing both accessible and efficient.
Olivier is a biochemical engineer who earned a PhD in viro-oncology from the WHO's International Agency for Research on Cancer in Lyon, France. In 2010 he co-initiated the design and setup of the French pre-industrial demonstrator TWB, an institute stimulating the bio-economy through public-private partnerships and industrial bio-solutions. As CTO, he oversees technology projects and leads the technical innovation of the demonstrator.
Connect on LinkedIn
Maria holds a PhD in Cellular and Molecular Biology from Paris V University, completed by an MBA at ESCP-Madrid. She has led sales for biotechnology companies internationally for more than 15 years. Since joining Beckman Coulter Life Sciences following the acquisition of Labcyte Inc. in 2019, she has held roles in marketing and business development, working with biofoundries and industrials to show how the company's solutions are essential parts of laboratory workflows.
Connect on LinkedInSee how automation across strain engineering and screening reduces the cost and uncertainty of moving to industrial scale.
Learn how miniaturized platforms deliver higher throughput with less space than traditional workflows.
Discover user-friendly equipment that makes next-generation biomanufacturing practical to adopt without disruption.